Learn More
Description
Specifications
Specifications
| Formulation | Lyophilized from sterile-filtered 30% acetonitrile, 0.1% TFA, 50μg BSA/μg rhOSM. |
| Preparation Method | Reconstitute to a final concentration of ≥10μg/mL in sterile PBS containing ≥0.1% BSA or HSA. |
| Purification Method | SDS-PAGE |
| Quantity | 10 μg |
| Source | E. coli |
| Immunogen | Oncostatin M |
| Storage Requirements | Following reconstitution, aliquot and freeze (−70°C). Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 3 months at −70°C. |
| Regulatory Status | RUO |
| Species | Human |
| Recombinant | Recombinant |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.